About

WHat do we do?

We are a professional services firm that developed and follows a unique, disciplined and unbiased approach to analyzing and commercializing lab tests based on its reimbursement outlook: The Reimbursement Model.

Who do we serve?

Investors and executive leadership launching new testing technology engage our firm for a reimbursement-driven roadmap to market. As a result, clients minimize financial risks, ramp up predictable revenue while sustaining growth and secure more desirable investment outcomes.

Why us?

  • 25+ years of experience refining The Reimbursement Model
  • Strategic launch and management of 20+ FDA and Laboratory Developed Test (LDT) products
  • Deep experience in laboratory commercialization and market access across Oncology,
    Women's Health, Neurology, Rare Disease and Pediatric, Microbiome, and Consumer Markets